Adipose tissue: enabler of prostate cancer aggressive behavior.
作者信息
Wade Cameron A, Kyprianou Natasha
机构信息
Departments of Urology, Molecular Biochemistry and Toxicology & Cancer Biology University of Kentucky College of Medicine, Lexington, KY, USA.
出版信息
Transl Androl Urol. 2019 Jul;8(Suppl 3):S242-S245. doi: 10.21037/tau.2019.01.07.
Abstract
摘要
相似文献
1
Adipose tissue: enabler of prostate cancer aggressive behavior.脂肪组织：前列腺癌侵袭性行为的促成因素。
Transl Androl Urol. 2019 Jul;8(Suppl 3):S242-S245. doi: 10.21037/tau.2019.01.07.
2
MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.磁共振波谱成像测量的前列腺周围脂肪组织脂肪酸组成与前列腺癌侵袭性的病理指标相关。
J Magn Reson Imaging. 2015 Sep;42(3):651-7. doi: 10.1002/jmri.24824. Epub 2014 Dec 19.
3
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.对局限性前列腺癌男性患者前列腺周围和皮下脂肪组织脂肪分解及脂肪细胞大小的评估。
Cancers (Basel). 2020 May 28;12(6):1385. doi: 10.3390/cancers12061385.
4
Linking obesogenic dysregulation to prostate cancer progression.将致肥胖失调与前列腺癌进展联系起来。
Endocr Connect. 2015 Dec;4(4):R68-80. doi: 10.1530/EC-15-0080.
5
Adipose tissue:Critical contributor to the development of prostate cancer.脂肪组织：前列腺癌发展的关键促成因素。
J Med Invest. 2018;65(1.2):9-17. doi: 10.2152/jmi.65.9.
6
Influence of adipocytokines in periprostatic adipose tissue on prostate cancer aggressiveness.前列腺周围脂肪组织中脂肪细胞因子对前列腺癌侵袭性的影响。
Cytokine. 2016 Sep;85:148-56. doi: 10.1016/j.cyto.2016.06.019. Epub 2016 Jun 29.
7
Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness.前列腺周围脂肪组织作为前列腺癌侵袭性的调节因子。
J Urol. 2009 Oct;182(4):1621-7. doi: 10.1016/j.juro.2009.06.015. Epub 2009 Aug 15.
8
Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.高危前列腺癌男性的皮下脂肪组织特征与生化复发风险
Urol Oncol. 2017 Nov;35(11):663.e15-663.e21. doi: 10.1016/j.urolonc.2017.07.012. Epub 2017 Aug 7.
9
Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma.人前列腺周围白色脂肪组织富含基质祖细胞，是前列腺肿瘤基质的潜在来源。
Exp Biol Med (Maywood). 2012 Oct;237(10):1155-62. doi: 10.1258/ebm.2012.012131. Epub 2012 Oct 4.
10
Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.前列腺周围脂肪组织转录组揭示了一种高危前列腺癌的特征性诊断方法。
Endocr Relat Cancer. 2018 May;25(5):569-581. doi: 10.1530/ERC-18-0058. Epub 2018 Mar 28.
引用本文的文献
1
Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review.前列腺周围脂肪组织在前列腺癌发病机制中的作用：一项叙述性综述
Cancers (Basel). 2025 Jan 23;17(3):372. doi: 10.3390/cancers17030372.
2
Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression.脂肪组织在前列腺癌进展中被忽视了。
Int J Mol Sci. 2024 Nov 12;25(22):12137. doi: 10.3390/ijms252212137.
3
The role of adipose stroma in prostate cancer aggressiveness.脂肪基质在前列腺癌侵袭性中的作用。
Transl Androl Urol. 2019 Jul;8(Suppl 3):S348-S350. doi: 10.21037/tau.2019.04.07.
本文引用的文献
1
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.靶向 FOXA1 介导的 TGF-β 信号抑制可抑制去势抵抗性前列腺癌的进展。
J Clin Invest. 2019 Feb 1;129(2):569-582. doi: 10.1172/JCI122367. Epub 2018 Dec 18.
2
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.肥胖在肿瘤进展和 PD-1 检查点阻断过程中对 T 细胞功能的矛盾影响。
Nat Med. 2019 Jan;25(1):141-151. doi: 10.1038/s41591-018-0221-5. Epub 2018 Nov 12.
3
Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance.靶向脂肪基质细胞可抑制前列腺癌上皮间质转化和化疗耐药性。
Oncogene. 2019 Mar;38(11):1979-1988. doi: 10.1038/s41388-018-0558-8. Epub 2018 Oct 25.
4
TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer.转化生长因子-β受体I抑制剂在晚期前列腺癌临床前模型中增强对恩杂鲁胺的反应。
Prostate. 2019 Jan;79(1):31-43. doi: 10.1002/pros.23708. Epub 2018 Aug 28.
5
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.髓细胞分泌的白细胞介素-23 驱动去势抵抗性前列腺癌。
Nature. 2018 Jul;559(7714):363-369. doi: 10.1038/s41586-018-0266-0. Epub 2018 Jun 27.
6
Profiling Prostate Cancer Therapeutic Resistance.前列腺癌治疗抵抗的特征分析。
Int J Mol Sci. 2018 Mar 19;19(3):904. doi: 10.3390/ijms19030904.
7
Cancer statistics, 2018.癌症统计数据，2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
8
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.临床局限性前列腺癌：AUA/ASTRO/SUO 指南。第 I 部分：风险分层、共同决策和治疗选择。
J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15.
9
Navigating the evolving therapeutic landscape in advanced prostate cancer.探索晚期前列腺癌不断演变的治疗格局。
Urol Oncol. 2017 May;35S:S1-S13. doi: 10.1016/j.urolonc.2017.01.020. Epub 2017 Mar 7.
10
Obesity and cancer--mechanisms underlying tumour progression and recurrence.肥胖与癌症——肿瘤进展与复发的潜在机制。
Nat Rev Endocrinol. 2014 Aug;10(8):455-465. doi: 10.1038/nrendo.2014.94. Epub 2014 Jun 17.
Zotero 插件